...
首页> 外文期刊>Nature Communications >EphB3 suppresses non-small-cell lung cancermetastasis via a PP2A/RACK1/Akt signallingcomplex
【24h】

EphB3 suppresses non-small-cell lung cancermetastasis via a PP2A/RACK1/Akt signallingcomplex

机译:EphB3通过PP2A / RACK1 / Akt信号复合物抑制非小细胞肺癌转移

获取原文
获取原文并翻译 | 示例
           

摘要

Eph receptors are implicated in regulating the malignant progression of cancer. Here we find thatdespite overexpression of EphB3 in human non-small-cell lung cancer, as reported previously, theexpression of its cognate ligands, either ephrin-B1 or ephrin-B2, is significantly downregulated,leading to reduced tyrosine phosphorylation of EphB3. Forced activation of EphB3 kinase inEphB3-overexpressing non-small-cell lung cancer cells inhibits cell migratory capability in vitroas well as metastatic seeding in vivo. Furthermore, we identify a novel EphB3-binding protein,the receptor for activated C-kinase 1, which mediates the assembly of a ternary signal complexcomprising protein phosphatase 2A, Akt and itself in response to EphB3 activation, leading toreduced Akt phosphorylation and subsequent inhibition of cell migration. our study revealsa novel tumour-suppressive signalling pathway associated with kinase-activated EphB3 innon-small-cell lung cancer, and provides a potential therapeutic strategy by activating EphB3signalling, thus inhibiting tumour metastasis.
机译:Eph受体参与调节癌症的恶性进展。在这里,我们发现尽管在人类非小细胞肺癌中EphB3过度表达,但其同源配体ephrin-B1或ephrin-B2的表达却显着下调,导致EphB3的酪氨酸磷酸化降低。 EphB3过表达的非小细胞肺癌细胞中EphB3激酶的强制激活抑制了体外细胞迁移能力以及体内转移性播种。此外,我们确定了一种新型的EphB3结合蛋白,即活化的C激酶1的受体,该受体介导包含蛋白磷酸酶2A,Akt及其自身的三元信号复合体的组装,以响应EphB3的激活,从而导致Akt磷酸化水平的降低和随后的抑制作用。细胞迁移。我们的研究揭示了一种与激酶激活的非小细胞肺癌相关的EphB3相关的新型肿瘤抑制信号通路,并通过激活EphB3信号传导提供了潜在的治疗策略,从而抑制了肿瘤转移。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号